TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06703073: Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)

Sponsor: PPD Development, LP · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 600 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$6,673,200

Rescue Site Savings

+$4,415,600

Unlock Full NCT06703073 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06703073 Rescue Dossier →